Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,134
Closed -$415K 6
2018
Q4
$415K Sell
2,134
-16
-0.7% -$3.12K 0.9% 47
2018
Q3
$446K Sell
2,150
-165
-7% -$32.5K 0.76% 53
2018
Q2
$427K Sell
2,315
-287
-11% -$50.8K 0.73% 57
2018
Q1
$444K Sell
2,602
-73
-3% -$13.4K 0.79% 56
2017
Q4
$465K Sell
2,675
-78
-3% -$13.8K 0.77% 58
2017
Q3
$513K Buy
2,753
+190
+7% +$33.7K 0.89% 42
2017
Q2
$441K Buy
2,563
+143
+6% +$23.3K 0.82% 59
2017
Q1
$397K Sell
2,420
-281
-10% -$46.7K 0.72% 65
2016
Q4
$395K Buy
2,701
+346
+15% +$52.1K 0.75% 62
2016
Q3
$393K Sell
2,355
-40
-2% -$6.76K 0.77% 65
2016
Q2
$331K Buy
2,395
+146
+6% +$22.7K 0.62% 66
2016
Q1
$337K Buy
2,249
+12
+0.5% +$1.78K 0.59% 69
2015
Q4
$363K Sell
2,237
-158
-7% -$24.8K 0.65% 62
2015
Q3
$331K Sell
2,395
-87
-4% -$13.7K 0.61% 69
2015
Q2
$381K Sell
2,482
-55
-2% -$8.81K 0.52% 77
2015
Q1
$406K Buy
2,537
+482
+23% +$75.9K 0.57% 67
2014
Q4
$327K Sell
2,055
-285
-12% -$44.4K 0.36% 111
2014
Q3
$329K Buy
2,340
+532
+29% +$69.5K 0.38% 114
2014
Q2
$214K Buy
+1,808
New +$209K 0.26% 164

Other funds holding AMGN

Banced Corp's AMGN Position: Q1 2019 in Review

Banced Corp sold out of Amgen (AMGN) in Q1 2019, closing a stake of 2,134 shares — an estimated $415K sold.

Banced Corp first reported a position in AMGN in Q2 2014 and held it in 19 quarters. The position peaked at $513K in Q3 2017. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Banced Corp reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Banced Corp sold 2,134 Amgen shares in Q1 2019, an estimated $415K.
  • Banced Corp first reported a position in Amgen in Q2 2014 and held it in 19 quarters.
  • Banced Corp's Amgen position peaked at $513K in Q3 2017.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Banced Corp's 13F filing for Q1 2019.